Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 741-749

  Rebrin, Kerstin ^a   Steil, Garry M ^a   Mittelman, Steven D ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

adipose tissue; free fatty acids; hepatic glucose output; insulin action; lipolysis

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; LIPOSYN; SOMATOSTATIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; GLYCEROL BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0029861999     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118846     Document Type: Article

References (49)

1. Rebrin, K., G.M. Steil, L. Getty, and R.N. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
2. Ader, M., and R.N. Bergman. 1990. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol. 258: E1020-E1032.
3. Giacca, A., S.J. Fisher, Z. Quing Shi, R. Gupta, H.L.A. Lickley, and M. Vranic. 1992. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J. Clin. Invest. 90:1769-1777.
4. Prager, R., P. Wallace, and J.M. Olefsky. 1987. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 36:607-611.
5. Bradley, D.C., R.A. Poulin, and R.N. Bergman. 1993. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes. 42:296-306.
6. Finegood, D.T., R.N. Bergman, and M. Vranic. 1987. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 36:914-924.
7. Molina, J.M., A.D. Baron, S.V. Edelman, G. Brechtel, P. Wallace, and J.M. Olefsky. 1990. Use of variable tracer infusion method to determine glucose turnover in humans. Am. J. Physiol. 258:E16-E23.
8. Poulin, R.A., G.M. Steil, D.M. Moore, M. Ader, and R.N. Bergman. 1994. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes. 43:180-190.
9. Bergman, R.N., D.C. Bradley, and M. Ader. 1993. On insulin action in vivo: the single gateway hypothesis. Adv. Exp. Med. Biol. 334:181-198.
10. Zambon, A., S.I. Hashimoto, and J.D. Brunzell. 1993. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J. Lipid Res. 34:1021-1028.
11. Andersen, L. B. Dinesen, P.N. Jorgensen, F. Poulsen, and M.E. Roder. 1993. Enzyme immunoassay for intact human insulin in serum or plasma. Clin. Chan. 39:578-582.
12. Bergmeyer, H.U., J. Bergmeyer, and M, Grassle. 1983. Methods in enzymatic analysis. Verlag Chemie, Akademie Press. 504 pp.
13. Cersosimo, E., R.L. Judd, and J.M. Miles. 1994. Insulin regulation of renal glucose metabolism in conscious dogs. J. Clin. Invest. 93:2584-2589.
14. Lewis, G.F., B. Zinman, Y. Groenewoud, M. Vranic, and A. Giacca. 1996. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 45:454-462.
15. Cherrington, A.D., P.E. Williams, G.I. Shulman, and W.W. Lacy. 1981. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes. 30:180-187.
16. Pagliassotti, M.J., L.C. Holste, M.C. Moore, D.W. Neal, and A.D. Cherrington. 1996. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J. Clin. Invest. 97:81-91.
17. Cherrington, A.D., J.E. Liljenquist, G.I. Shulman, P.E. Williams, and W.W. Lacy. 1979. Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am. J. Physiol. 236:E263-E271.
18. Carlson, M.G., W.L. Snead, and P.J. Campbell. 1993. Regulation of free fatty acid metabolism by glucagon. J. Clin. Endocrinol. & Metab. 77:11-15.
19. Schade, D.S., and R.P. Eaton. 1975. Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects. Diabetes. 24:502-509.
20. Perea, A., F. Clement, J. Martinell, M.L. Villanueva-Penacarrillo, and I. Valverde. 1995. Physiologic effect of glucagon in human isolated adipocytes. Horm. Metab. Res. 27:372-375.
21. Jensen, M.D., V.J. Heiling, and J.M. Miles. 1991. Effects of glucagon on free fatty acid metabolism in humans. J. Clin. Endocrinol. & Metab. 72:308-315.
22. Jeng, C.Y., W.H.H. Sheu, J.B. Jaspan, K.S. Polonsky, Y.-D.I. Chen, and U.M. Reaven. 1993. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. & Metab. 77:6-10.
23. Keller, U., and J.M. Miles. 1991. Growth hormone and lipids. Horm. Res. 36(Suppl. 1):36-40.
24. Copeland, K.E., and K.S. Nair. 1994. Acute growth hormone effects on aminoacid and lipid metabolism. J. Clin. Endocrinol & Metab. 78:1040-1047.
25. De Pergola, G., M. Cignarelli, G. Nardelli, G. Garruti, M. Corso, S. Di Paolo, F. Cardone, and R. Giorgino. 1989. Influence of lactate on isoproterenol-induced lipolysis and beta-adrenoceptors distribution in human fat cells. Horm. Metab. Res. 21:210-21.1.
26. Jahoor, F., S. Klein, and R.R. Wolfe. 1992. Mechanism of regulation of glucose production by lipolysis in humans. Am. J. Physiol. 262:E353-E358.
27. Nurjhun, N., P.J. Campbell, F.P. Kennedy, J.M. Miles, and J.E. Gerich. 1986. Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes. 35:1326-1331.
28. Bortz, W.M., P. Paul, A.C. Haff, and W.L. Holmes. 1972. Glycerol turnover and oxidation in man. J. Clin. Invest. 51:1537-1546.
29. Boden, G., X. Chen, J. Ruiz, J.V. White, and L. Rossetti. 1994. Mechanism of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-2446.
30. Nurjhan, N., A. Consoli, and J.E. Gerich. 1992. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:169-175.
31. Fanelli, C., S. Calderone, L. Epifano, A. De Vincenzo, F. Modarelli, S. Pampanelli, G. Perriello, P. De Feo, P. Brunetti, and J.E. Gerich. 1993. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilisation in humans. J. Clin. Invest. 92:1617-1622.
32. Williamson, J.R., R.A. Kreisberg, and P.W. Felts. 1966. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA. 56:247-254.
33. Puhakaincn, I., and H. Yki-Jarvinen. 1993. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes. 42: 1694-1699.
34. Clore, J.N., J.E. Nestler, and W.G. Blackard. 1989. Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Diabetes. 38: 285-290.
35. Clore, J.N., P.S. Glickman, S.T. Helm, J.E. Nestler, and W.G. Blackard, 1991. Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes: 40:1033-1040.
36. Chen, Y.-D.I., A.L.M. Swislocki, C.-Y. Jeng, J.-H. Juang, and G.M. Reaven. 1988. Effect of time on measurement of hepatic glucose production. J. Clin. Endocrinol. & Metab. 67:1084-1088.
37. Hother-Nielsen, O., and H. Beck-Nielsen. 1990. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glueose infusion. Diabetologia. 33:603-610.
38. Jeng, C.Y., W.H.H. Sheu, M.M.T. Fuh, Y.-D.I. Chen, and G.M. Reaven. 1994. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes. 43:1440-1444.
39. Johnston, P., C. Hollenheck, W. Sheu, Y.-D.I. Chen, and G.M. Reaven. 1990. Acute changes in plasma non-esterified fatly acid concentration do not change hepatic glucose production in people with type 2 diabetes. Diabetic Med. 7:871-875.
40. Fulcher, G.R., M. Walker, C. Catalano, L. Agius, and K.G.M.M. Alberti. 1992. Metabolic effects of suppression of nonesterified fatty acid levels with Acipimox in obese NIDDM subjects. Diabetes. 41:1400-1408.
41. Puhakainen, I., V.A. Koivisto, and H. Yki-Jarvinen. 1991. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes. 40:1319-1327.
42. Bevilacqua, S., R.C. Bonadonna, G. Buzzigoli, C. Boni, D. Ciociaro, F. Maccari, M.A. Giorico, and E. Ferrannini. 1987. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metab. Clin. Exp. 36:502-506.
43. Chen, Y.-D.I., A. Golay, A.L.M. Swislocki, and G.M. Reaven. 1987. Resistance to insulin suppression of plasma free fatly acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. & Metab. 64:17-21.
44. Golay, A., Y.-D.I. Chen, and G.M. Reaven. 1986. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin. Endocrinol. & Metab. 62:1081-1088.
45. Reaven, G.M. 1995. The fourth musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia. 38:3-13.
46. Groop, L.C., R.C. Bonadonna, S. Del Prato, K. Ratheiser, K. Zyck, E. Ferrannini, and R.A. DeFronzo. 1989. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J. Clin. Invest. 84:205-213.
47. Taskinen, M.R., C. Bogardus, A. Kennedy, and B.V. Howard. 1985. Multiple disturbances of free fatfy acid metabolism in non-insulin-dependent diabetes. j. Clin. Invest. 76:637-644.
48. Groop, L.C., C. Saloranta, M. Shank, R.C. Bonadonna, E. Ferrannini, and R.A. DeFronzo. 1991. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. & Metab. 72:96-107.
49. Magnusson, I., D.L. Rothman, L.D. Katz, R.G. Shulman, and G.I. Shulman. 1992. Increased rate of gluconeogenesis in type II diabetes mellitus. J. Clin. Invest. 90:1323-1327.